Our NAFLD phenotype is based on a few key components: chronically elevated ALT, exclusion of viral, cholestatic and other hereditary liver diseases, and exclusion of persons with alcohol-related cirrhosis. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.